SCHEMBL24814388

SCHEMBL24814388

O=C(N1Cc2ccccc2C1)C(F)(F)CSc1ccccn1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ MAPT P10636 4/20 0.44
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ NPC1 O15118 3/20 0.44
▸ RAB9A P51151 3/20 0.44
▸ LMNA P02545 3/20 0.44
▸ MEN1 O00255 2/20 0.44
▸ L3MBTL1 Q9Y468 1/20 0.44
▸ HSD17B10 Q99714 3/20 0.43
▸ HPGD P15428 4/20 0.41
▸ POLB P06746 2/20 0.41
▸ PKM P14618 1/20 0.40
▸ TSHR P16473 1/20 0.39
▸ NAMPT P43490 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29986086 1.00 ALDH1A1 (0.44) ALDH1A1KMT2AMAPTSMN1; SMN2NPC1
SCHEMBL29986714 0.77 HSD17B10 (0.64) ALDH1A1KMT2AMAPTSMN1; SMN2NPC1
SCHEMBL24815668 0.77 HSD17B10 (0.64) ALDH1A1KMT2AMAPTSMN1; SMN2NPC1
SCHEMBL29986268 0.72 NAMPT (0.58) ALDH1A1SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL24814389 0.72 NAMPT (0.58) ALDH1A1SMN1; SMN2NPC1RAB9ALMNA
SCHEMBL26845985 0.71 RIPK1 (0.52) NPC1RAB9ANAMPT
SCHEMBL24817149 0.71 LMNA (0.60) ALDH1A1KMT2AMAPTSMN1; SMN2NPC1
SCHEMBL24814439 0.71 NAMPT (0.46) ALDH1A1NPC1RAB9AHSD17B10HPGD
SCHEMBL29986479 0.71 NAMPT (0.46) ALDH1A1NPC1RAB9AHSD17B10HPGD
SCHEMBL795721 0.70 MAPT (0.56) ALDH1A1KMT2AMAPTSMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2023-11-28 — — US disclosed
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2022-12-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411418-A1 CDGSH IRON SULFUR DOMAIN 2 ACTIVATORS AND USE THEREOF CISD2, CISD1, FECH ALDH1A1 3533/4885KMT2A 3256/4885MAPT 4407/4885
US-11827629-B2 CDGSH iron sulfur domain 2 activators and use thereof CISD2, CISD1, FECH ALDH1A1 3533/4885KMT2A 3256/4885MAPT 4407/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback